Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	140	142	181	698	765	2,236
Market Cap Growth	-9.65%	-21.59%	-74.06%	-8.81%	-65.78%	825.56%
Enterprise Value	180	169	223	541	461	1,979
Last Close Price	15.05	16.62	28.00	112.00	166.60	490.00
PE Ratio	24.92	1043.26	-	-	-	-
PS Ratio	404.64	-	-	-	5.28	67.31
PB Ratio	3.02	10.29	-4.03	64.71	5.82	12.79
P/TBV Ratio	3.25	10.29	-	64.71	5.82	12.79
P/OCF Ratio	-	-	-	-	114.40	-
EV/Sales Ratio	511.81	-	-	-	3.18	59.60
Debt / Equity Ratio	1.95	6.65	-4.43	15.08	0.37	0.23
Asset Turnover	0.00	-	-	-	0.42	0.14
Quick Ratio	2.16	0.80	1.30	2.12	3.53	5.67
Current Ratio	2.30	0.94	1.78	2.28	3.69	5.79
Return on Equity (ROE)	15.96%	-	-	-258.04%	-42.83%	-141.00%
Return on Assets (ROA)	-40.12%	-30.43%	-34.48%	-31.96%	-11.55%	-23.17%
Return on Invested Capital (ROIC)	-52.45%	-58.47%	-74.51%	-63.51%	-20.34%	-51.97%
Return on Capital Employed (ROCE)	-85.40%	-123.10%	-75.10%	-68.40%	-23.70%	-29.70%
Earnings Yield	3.80%	0.10%	-62.84%	-35.85%	-8.57%	-3.99%
FCF Yield	-16.45%	-105.01%	-69.26%	-34.20%	-0.38%	-4.21%
Buyback Yield / Dilution	-19.92%	-21.40%	-18.44%	-17.86%	-14.93%	-40.85%

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q